News
7hon MSN
Jameela Jamil defends Serena Williams’ right to choose—but cautions the risk of weight loss drugs
Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills ...
Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
With 23 Grand Slam singles titles and four Olympic gold medals, Serena Williams is undeniably a superathlete. But the 43-year ...
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...
Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results